Related Experiment Video
Updated: Jun 24, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin
Rajashree Hirlekar1, Vilasrao Kadam
1Department of Pharmaceutics, Bharati Vidyapeeth's College of Pharmacy,CBD Belapur, Navi Mumbai, Maharashtra, India. rshirlekar@rediffmail.com
Abstract:
The aim of the present work was to improve the solubility and dissolution profile of irbesartan (IRB), a poorly water-soluble drug by formation of inclusion complex with beta-cyclodextrin (betaCD). Phase solubility studies revealed increase in solubility of the drug upon cyclodextrin addition, showing A(L)-type of graph with slope less than one indicating formation of 1:1 stoichiometry inclusion complex. The stability constant (K(s)) was found to be 104.39 M(-1). IRB-betaCD binary systems were prepared by cogrinding, kneading using alcohol, kneading using aqueous alcohol, and coevaporation methods. Characterization of the binary systems were carried out by differential scanning calorimetry, Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction, and proton nuclear magnetic resonance. The dissolution profiles of inclusion complexes were determined and compared with those of IRB alone and physical mixture. Among the various methods, coevaporation was the best in which the solubility was increased and dissolution rate of the drug was the highest. The study indicated the usefulness of cyclodextrin technology to overcome the solubility problem of IRB.
Related Concept Videos
Modified-Release Drug Delivery Systems: Bioavailability
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Product Performance: In Vitro–In Vivo Correlation
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients

